The “MIA” species of GHRH-Ants are the result of our latest efforts in synthesizing antagonistic GHRH analogs, with MIA-602 representing a novel therapeutic approach in the treatment of refractory AML [27, 29, 31]. Here, GHRH is linked to acute myeloid leukemia.